AMGN vs NABL · P/E 24, rev $10.05B vs P/E 103, rev $270.6M
Amgen Inc (AMGN) versus N-Able Inc (NABL) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
N-Able Inc (NABL) is a information technology services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NABL revenue for 2026-06-30 was $270.6M. Net income was $77.0K. NABL currently screens at market cap $1.56B and trailing P/E 103.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NABL currently screens at market cap $1.56B and trailing P/E 103.1.
Not investment advice. Open the AMGN and NABL stock pages for the full models.
Not investment advice.